A Major Regional Measles Outbreak: Description of Hospitalized Cases in 2017-2018 at Bordeaux University Hospital, France.
measles
measles inclusion-body encephalitis
outbreak
vaccination
vaccination failure
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
17
06
2020
accepted:
10
08
2020
entrez:
18
3
2021
pubmed:
19
3
2021
medline:
19
3
2021
Statut:
epublish
Résumé
Measles remains endemic worldwide, despite current vaccination recommendations, and is associated with high morbidity and mortality rates. We describe all cases hospitalized in Bordeaux University Hospital (BUH), the starting point of a national significant measles outbreak in 2017-2018. In this retrospective study, we included all patients hospitalized in BUH from September 1, 2017, to May 31, 2018. Inclusion criteria were age >1 year, clinical symptoms, and biological confirmation by measles immunoglobulin M or measles reverse transcription polymerase chain reaction positivity. We included 171 patients. Most patients were immunocompetent; only 19% had preexisting medical histories. Most patients had rash and fever (97%), but some cases were atypical and difficult to diagnose. Köplik's spots were reported in 66 cases (38%). The most frequent biological markers were blood inflammation markers (96%) and lymphopenia (81%). Unexpectedly, we found hyponatremia (<135 mmol/L) in 40% of patients. We identified peaks in January and March, corresponding to 76 D8 genotypes and 28 B3 strains. The following complications were reported in 65 patients (38%): pneumonia, hepatitis, and keratitis; 10 had neurological symptoms. One patient had Guillain-Barré syndrome, and a young immunocompromised patient died from measles inclusion-body encephalitis. Most of the patients (80%) had not been correctly vaccinated, including 28 health care workers. Some patients (n = 43, 25%) developed measles despite having plasma IgG. These included 12 possible vaccination failure cases. During the BUH outbreak, measles was often complicated and sometimes atypical. Vaccination coverage was dramatically insufficient. We also describe vaccination failure cases that must be better investigated.
Sections du résumé
BACKGROUND
BACKGROUND
Measles remains endemic worldwide, despite current vaccination recommendations, and is associated with high morbidity and mortality rates. We describe all cases hospitalized in Bordeaux University Hospital (BUH), the starting point of a national significant measles outbreak in 2017-2018.
METHODS
METHODS
In this retrospective study, we included all patients hospitalized in BUH from September 1, 2017, to May 31, 2018. Inclusion criteria were age >1 year, clinical symptoms, and biological confirmation by measles immunoglobulin M or measles reverse transcription polymerase chain reaction positivity.
RESULTS
RESULTS
We included 171 patients. Most patients were immunocompetent; only 19% had preexisting medical histories. Most patients had rash and fever (97%), but some cases were atypical and difficult to diagnose. Köplik's spots were reported in 66 cases (38%). The most frequent biological markers were blood inflammation markers (96%) and lymphopenia (81%). Unexpectedly, we found hyponatremia (<135 mmol/L) in 40% of patients. We identified peaks in January and March, corresponding to 76 D8 genotypes and 28 B3 strains. The following complications were reported in 65 patients (38%): pneumonia, hepatitis, and keratitis; 10 had neurological symptoms. One patient had Guillain-Barré syndrome, and a young immunocompromised patient died from measles inclusion-body encephalitis. Most of the patients (80%) had not been correctly vaccinated, including 28 health care workers. Some patients (n = 43, 25%) developed measles despite having plasma IgG. These included 12 possible vaccination failure cases.
CONCLUSIONS
CONCLUSIONS
During the BUH outbreak, measles was often complicated and sometimes atypical. Vaccination coverage was dramatically insufficient. We also describe vaccination failure cases that must be better investigated.
Identifiants
pubmed: 33732748
doi: 10.1093/ofid/ofaa332
pii: ofaa332
pmc: PMC7958733
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa332Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Dermatology. 2010;220(3):280-1
pubmed: 20110626
Vaccine. 2003 Oct 1;21(27-30):4210-4
pubmed: 14505900
Euro Surveill. 2017 Apr 27;22(17):
pubmed: 28488998
Clin Vaccine Immunol. 2016 Aug 05;23(8):707-16
pubmed: 27335386
Nat Rev Dis Primers. 2016 Jul 14;2:16049
pubmed: 27411684
J Infect Dis. 2004 May 1;189 Suppl 1:S4-16
pubmed: 15106083
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1228-1233
pubmed: 27832050
J Indian Med Assoc. 2011 Sep;109(9):666-7
pubmed: 22480102
J Pediatr. 1977 Nov;91(5):715-8
pubmed: 909009
Lancet Infect Dis. 2019 Nov;19(11):1235-1245
pubmed: 31548079
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD001479
pubmed: 16235283
Clin Infect Dis. 2018 Oct 15;67(9):1315-1319
pubmed: 29878209
Front Microbiol. 2019 Feb 18;10:269
pubmed: 30833942
Euro Surveill. 2017 Oct;22(42):
pubmed: 29067903
PLoS One. 2019 Oct 17;14(10):e0224009
pubmed: 31622429
Clin Infect Dis. 2020 Mar 3;70(6):1060-1067
pubmed: 31056637
Lancet. 2017 Dec 2;390(10111):2490-2502
pubmed: 28673424
Expert Rev Vaccines. 2019 Jan;18(1):75-87
pubmed: 30585753